Tribestin

Tribestin at a Glance

Tribestin is a sulfated spirostanol saponin — a diosgenin core carrying a two-sugar chain at C-3, with a sulfate ester sitting on the inner glucose. C₃₉H₆₁NaO₁₅S, 824.9 Da as the sodium salt (PubChem CID 177824630). It has been reported from Tribulus terrestris and from nothing else.

It exists here for one reason, and it is not a drug effect. Tribestin and its open-ring partner prototribestin are the two compounds whose presence or absence sorts Tribulus terrestris into two chemically distinct plants. In the nine-country LC-ESI/MS/MS survey that established this, material from Bulgaria, Turkey, Greece, Serbia, Macedonia, Georgia and Iran contained both; material from Vietnam and India contained neither ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. That is a binary test, and binary tests are rare and valuable in plant chemistry.

Its biological record, by contrast, is a single line in a single paper. In a 2009 screen of Tribulus and Smilax compounds against a multidrug-resistant mouse lymphoma line, tribestin was one of five compounds described as showing “moderate MDR reversal activity” — no compound-specific number, no follow-up, no replication in the seventeen years since ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. That is the whole of it.

Three claims routinely land on this molecule that do not belong to it, and they are dealt with explicitly below: it is not the Bulgarian aphrodisiac product Tribestan (a near-identical string, an entirely different thing); it is not a testosterone precursor; and the Tribulus sexual-function trials are whole-extract trials that say nothing about it.

Tribestin Is Not Tribestan

This has to come first, because the two words differ by one letter and the confusion is unavoidable in any search.

Tribestan (with an a) is a pharmaceutical product — a standardised Tribulus terrestris tablet manufactured by Sopharma in Bulgaria, in the literature since at least 1982, when a German-language Pharmazie note described a method for determining its furostanol saponin content ^{9Reference 9Gjulemetowa R et al. · 1982Gjulemetowa R, Tomowa M, Simowa M, Pangarowa T, Peewa S (1982). [Determination of furostanol saponins in the preparation Tribestan] [in German]. Pharmazie 37:296. https://pubmed.ncbi.nlm.nih.gov/6896581/View study →}. It is the material behind essentially all of the herb’s real clinical evidence, including the 180-patient phase IV randomised, double-blind, placebo-controlled trial that found improvement on the International Index of Erectile Function and on sexual desire versus placebo ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}.

Tribestin (with an i) is a single molecule, named two decades later, presumably after the plant and the product it came out of.

The disambiguation is checkable, and here is how. PubMed does not stem the two together. A search for tribestin returns two records, both about Tribulus saponin chemistry ^{1,2Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. A search for Tribestan maps to a Supplementary Concept and returns eleven records, all about the product — clinical trials in infertile men, veterinary use in rams, sperm-parameter comparisons ^{8,9Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →Reference 9Gjulemetowa R et al. · 1982Gjulemetowa R, Tomowa M, Simowa M, Pangarowa T, Peewa S (1982). [Determination of furostanol saponins in the preparation Tribestan] [in German]. Pharmazie 37:296. https://pubmed.ncbi.nlm.nih.gov/6896581/View study →}. The two result sets do not overlap at all. If a source cites “Tribestan” for a molecular claim, or “tribestin” for a clinical one, it has conflated them.

The practical consequence matters more than the pedantry: the entire human evidence base belongs to the product, and none of it belongs to the molecule. Tribestan is standardised to furostanol saponins as a class — and tribestin is a spirostanol, so it is not even inside the fraction the tablet is titrated on.

What Tribestin Actually Is — and Its Unsulfated Twin

The structure is worth spelling out, because two relationships fall straight out of it and neither is obvious from the name.

Tribestin is diosgenin 3-O-α-L-rhamnopyranosyl-(1→2)-β-D-4-O-sulfo-glucopyranoside: a (25R)-spirost-5-en-3β-ol aglycone (diosgenin), a glucose on C-3, a rhamnose on that glucose’s 2-position, and a sulfate ester on its 4-position. Sulfated steroidal saponins are genuinely uncommon — the category of sulfur-containing plant metabolites is dominated by the glucosinolates of the cabbage family, and tribestin turns up in cross-species surveys of that category as one of the handful of sulfated saponins known ^{10Reference 10Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}. Within Tribulus, sulfated saponins have only ever been reported from Bulgarian-origin material ^{7Reference 7Kostova I · 2005Saponins in Tribulus terrestris — chemistry and bioactivityView study →}.

Relationship one: strip the sulfate and you get a compound with its own name. Tribestin minus the sulfate is prosapogenin A of dioscin (C₃₉H₆₂O₁₂, PubChem CID 11061578) — the well-known partial-hydrolysis product of dioscin, which is the same molecule with a second rhamnose. So the family runs: dioscin → (remove one rhamnose) prosapogenin A of dioscin → (add a 4′-sulfate) tribestin → (add a C-26 glucose and open the F ring) prototribestin.

That relationship turns out to be the most informative thing in tribestin’s pharmacological record, because both tribestin and prosapogenin A of dioscin were in the same 2009 cell screen, and both were described identically — “moderate MDR reversal activity” ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. The sulfate group, tribestin’s one structural distinction, made no reportable difference in the only experiment where the sulfated and unsulfated forms were run side by side. That is a weak observation from a qualitative descriptor, but it is the only direct evidence anyone has about what the sulfate does, and it points at “not much.”

Relationship two: the aglycone is diosgenin, and that means nothing hormonal. Diosgenin was the industrial feedstock from which progesterone and cortisone were once semi-synthesised by the Marker degradation — acetic anhydride, chromium oxidation, pyrolysis, in a factory. No organism performs that chemistry. There is no human enzyme that converts diosgenin, or any spirostanol sapogenin, into progesterone, DHEA or testosterone. Carrying a steroid skeleton describes a carbon framework, not an endocrine effect, and for a herb marketed almost entirely as a testosterone booster this is the single most important thing to keep straight. See diosgenin for the full account of that myth.

The Chemotype Story, and Where Tribestin Beats Its Partner

Tribulus supplements are sold on provenance. “Bulgarian tribulus” is the premium designation because the Bulgarian standardised extract is the material behind the herb’s real clinical evidence ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}, and everything downstream assumes the powder in the capsule resembles the powder in the study.

The industry’s usual test for this is protodioscin content. That test is weak, and the reason is structural rather than analytical: protodioscin is present nearly everywhere the plant grows and merely varies in amount — by more than twenty-fold — so a low reading is ambiguous between wrong origin, wrong plant part, wrong season and poor extraction ^{1,4Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}.

Tribestin and prototribestin are not like that. In the 2008 survey they were present together in every European and west-Asian sample and absent together from every Indian and Vietnamese one ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. Presence/absence beats a twenty-fold gradient, and the authors said so directly: prototribestin and tribestin could serve as chemotaxonomic markers of a chemotype typical of southeastern Europe and western Asia.

Where tribestin adds something its partner cannot. Two things, both quantitative.

First, tribestin is not always the minor member of the pair. The compiled dataset makes this visible. In Serbian aerial parts, tribestin (210 mg/100 g) exceeds prototribestin (170) and protodioscin (200) — it is the most abundant of the seven markers measured in that sample ^{4Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}. The primary paper says the same in words, naming tribestin the main component of the aerial parts from Pomorie in Bulgaria and Niš in Serbia ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. Our own prototribestin page describes tribestin as “roughly an order of magnitude lower than prototribestin”; that is a fair average across the dataset, but it is not true at the top of the range, and the Serbian sample inverts it outright.

Second, tribestin’s country figures are clean where prototribestin’s are not. The compiled table’s prototribestin row repeats the Greek (220–790) and Macedonian (420–990) values verbatim from the protodioscin row directly above it — a transcription artefact rather than a coincidence across two compounds and two countries, and the reason those two rows are excluded from our prototribestin chart. The tribestin figures for the same two countries (Greece 24; Macedonia 7.3–10) match no other row in the table and are internally consistent with the neighbouring countries ^{4Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}. So for Greece and Macedonia, tribestin is currently the only usable sulfated-marker number in print.

Here is the full comparison, in one place, for the first time here.

Origin	Part	Tribestin	Prototribestin	Protodioscin
Bulgaria	aerial parts	2–220	130–2,200	109–1,530
Bulgaria	leaves	62	700	1,000–1,330
Bulgaria	fruits	0.9–3.4	21–28	240–500
Turkey	aerial parts	6.8–28	310–1,000	340–1,000
Turkey	fruits	0.5–1	17–65	10–60
Greece	aerial parts	24	220–790 (suspect)	220–790
Macedonia	aerial parts	7.3–10	420–990 (suspect)	420–990
Serbia	aerial parts	210	170	200
Georgia	aerial parts	6	240	560
Vietnam · India	aerial parts, fruits	not detected	not detected	present (low)

All values mg per 100 g dry weight, from the 2008 survey ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →} as compiled in the 2020 review ^{4Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}. Italicised cells are the suspected transcription duplicates. Iran is in the primary sample set and is described as marker-positive, but has no row in the compiled table for any of the three compounds.

The honest limit. Nobody has shown that European-chemotype tribulus works better because it contains tribestin. Tribestin is a fingerprint. It travels with the material the trials used. Those are different arguments and only the first one has evidence.

What It's Used For

One biological result exists, and it is a single qualitative phrase.In an mdr1-transfected mouse lymphoma screen, tribestin showed “moderate” multidrug-resistance reversal — alongside methylprotodioscin, pseudoprotodioscin, prosapogenin A of dioscin and 5-O-caffeoylshikimic acid. The panel’s growth-inhibitory ID₅₀ values spanned 12.64–20.62 µg/mL; no value specific to tribestin was published, and no selectivity index against normal cells was measured ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}.

Tribestin is one of the panel’s artefact-free datapoints — and this partly closes an open question.Batch 62 flagged that the panel’s best performer, methylprototribestin, is a 22-O-methyl furostanol and a probable methanol-extraction artefact. Tribestin cannot be that kind of artefact: it is a spirostanol, its F ring is already closed as a spiroketal, and there is no C-22 hydroxyl for methanol to methylate. Whatever the “moderate” activity is worth, it was measured on a compound that genuinely exists in the plant.

The sulfate appears to do nothing measurable.Tribestin and its unsulfated equivalent, prosapogenin A of dioscin, were in the same panel and drew the same description ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. One qualitative comparison is thin evidence, but it is all there is, and it does not support the sulfate being functionally important.

Nothing else has ever been done with this molecule.No receptor, no enzyme, no animal study, no pharmacokinetics, no toxicology, no clinical exposure. Its other appearances in the literature are analytical: a chemotype survey ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}, a re-isolation ^{5Reference 5Conrad J et al. · 2004A novel furostanol saponin from Tribulus terrestris of Bulgarian originView study →}, review catalogues ^{4,6,7Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →Reference 6Zhu W et al. · 2017ReviewA review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestrisView study →Reference 7Kostova I · 2005Saponins in Tribulus terrestris — chemistry and bioactivityView study →} and a sulfur-metabolite clustering exercise ^{10Reference 10Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}.

The tribulus sexual-function evidence is not tribestin’s.The randomised trials used the whole standardised extract, titrated on furostanol saponins — a fraction tribestin is not in ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}.

Evidence by IndicationStrength of support · Beta

Support is an experimental score — weighted by study type (human > animal > in vitro) and volume. A beta, not a validated metric. Read what the rows are: the well-supported application here is analytical, and the pharmacological row scores low because it is one qualitative descriptor in one shared panel.

The load-bearing result and the reason the page exists. Dinchev and colleagues analysed T. terrestris from Bulgaria, Greece, Serbia, Macedonia, Turkey, Georgia, Iran, Vietnam and India by LC-ESI/MS/MS for seven markers: protodioscin, prototribestin, pseudoprotodioscin, dioscin, tribestin, tribulosin and the flavonoid rutin ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}.

The European and west-Asian samples formed one coherent chemotype; the Vietnamese and Indian samples lacked both sulfated markers entirely, carried tribulosin in high amounts instead, and were dominated by compounds outside the marker set. Content varied strongly with plant part and growth stage — leaves and aerial parts far above fruit — and no correlation was found between burr morphology and chemistry, so the plant cannot be chemotyped by eye.

Later work has treated the finding as settled rather than re-testing it. Review compilations reproduce the table ^{4,6,7Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →Reference 6Zhu W et al. · 2017ReviewA review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestrisView study →Reference 7Kostova I · 2005Saponins in Tribulus terrestris — chemistry and bioactivityView study →}; a 2004 phytochemical study re-isolated known spirostanol saponins from Bulgarian aerial parts alongside the new furostanol tribol ^{5Reference 5Conrad J et al. · 2004A novel furostanol saponin from Tribulus terrestris of Bulgarian originView study →}; and a chemoinformatics survey of 692 plant species lists tribestin among sulfated plant metabolites, from Tribulus only ^{10Reference 10Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}.

Gap: eighteen years on, this remains one dataset. There is no independent replication of the presence/absence split, no survey of African, Australian or American Tribulus, no characterisation of what the Indian and Vietnamese chemotypes actually contain, and — critically for the practical use — no measurement of tribestin in any commercial supplement. There is also no commercial reference standard, which is the concrete reason the industry keeps standardising on protodioscin instead of on the better discriminator.

This is the entirety of tribestin’s biological literature, and it is important to state it at exactly its size. Ivanova and colleagues screened saponins and phenolics from T. terrestris and Smilax excelsa for reversal of multidrug resistance in a human mdr1 gene-transfected mouse lymphoma line, measuring antiproliferative effect and rhodamine-123 accumulation. Methylprototribestin was the most effective resistance modifier. Tribestin appears in one sentence: methylprotodioscin, pseudoprotodioscin, prosapogenin A of dioscin, tribestin and 5-O-caffeoylshikimic acid “showed moderate MDR reversal activity.” Growth-inhibitory ID₅₀ values across the whole compound set ranged 12.64 to 20.62 µg/mL. The checkerboard combination work with doxorubicin, and the recommendation for mouse xenograft follow-up, applied to methylprototribestin and the acetylated methylprotodioscin isomer mixture — not to tribestin ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}.

Two readings are worth keeping apart. In tribestin’s favour: unlike the panel’s headline compound, tribestin is not a plausible extraction artefact (see the takeaway above), so its datapoint is about a real plant constituent. Against: “moderate” is a descriptor, not a measurement; no ID₅₀ or reversal-fold figure was published for tribestin specifically; the ID₅₀ band of 12–21 µg/mL is roughly 15–25 µmol/L for a molecule of this mass, which is squarely the range where saponin surfactancy — non-specific membrane permeabilisation — routinely generates both antiproliferative readouts and apparent efflux inhibition; and no selectivity index against normal cells was reported.

Gap: one screen, one cell line, one laboratory, no replication in seventeen years, no in-vivo work despite the authors recommending it, and no membrane or haemolysis control to separate a P-glycoprotein effect from a detergent effect. Until that control exists, this should be read as a membrane result unless shown otherwise.

Mechanisms

There is no mechanism table in the ordinary sense, because no molecular target has been reported. What can honestly be tabulated is what was measured, and who owns it.

Target / property	What is known	Whose finding
Any receptor, enzyme or transporter	Nothing reported	—
P-glycoprotein / MDR reversal	”Moderate” activity, qualitative; no fold-reversal figure	Tribestin’s own, one screen ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}
Cell growth inhibition	Panel ID₅₀ 12.64–20.62 µg/mL; no tribestin-specific value; no normal-cell selectivity index	Panel-level ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}
Effect of the 4′-sulfate	No measurable difference from unsulfated prosapogenin A of dioscin in the same panel	Inference from ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}
Membrane surfactancy	Never measured for this compound. Directly demonstrated for the sibling spirostanol tribulosin on model bilayers	Class inference
NO/cGMP cavernosal relaxation	Proposed for the whole extract; attributed to protodioscin	Not tested for this molecule ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}
Androgen / progestogen activity	None reported, and none implied by the diosgenin skeleton	—
Chemotype discrimination	Present across southeastern Europe and western Asia; absent from India and Vietnam	Tribestin’s own, well documented ^{1,4Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}

Pharmacokinetics

There is no pharmacokinetic study of tribestin. No absorption figure, no bioavailability, no half-life, no metabolite identification, no tissue distribution, in any species. What follows is class reasoning and should be read as such.

At 825 Da with two sugars, a sulfate ester and multiple free hydroxyls, tribestin sits outside the range for passive intestinal absorption. The general expectation for steroidal saponins is that gut microbiota strip the sugars and the deglycosylated sapogenin is what reaches tissue — for tribestin that would be diosgenin, which has its own page and its own (non-hormonal) pharmacology. On that logic the systemically available product of eating tribestin is not tribestin.

The sulfate is the unstudied variable. It makes the molecule anionic and more water-soluble than a neutral saponin, and it is a plausible substrate for bacterial sulfatases — but nobody has looked, for tribestin or for prototribestin. Whether the sulfate comes off before or after the sugars, or whether the molecule is simply excreted intact, is genuinely unknown.

One adjacent measurement is worth knowing: a validated UHPLC-MS/MS study followed six Tribulus steroidal saponins in rat plasma after oral fruit extract and found all six quantifiable, so intact Tribulus saponins are not simply undetectable after an oral dose ^{12Reference 12Song X et al. · 2021AnimalPharmacokinetic comparisons of six steroid saponins in rat plasma following oral administration of crude and stir-fried Fructus Tribuli extracts by UHPLC-MS/MSView study →}. Tribestin was not among the six.

Clinical Trials

None. No trial, completed, ongoing or registered, has administered tribestin to a human being under any name. The clinical literature attached to this plant is whole-extract — and, as the disambiguation section above sets out, the product name in those trials is Tribestan, not this molecule.

Completed	Planned	Terminated	Preclinical
—(none)	—	—	1in-vitro MDR screen, panel-level ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}

Last checked: August 2026.

Furostanol In, Spirostanol Out: Tribestin Is the “After”

Tribestin and prototribestin are not two independent markers that happen to co-occur. They are the two ends of one chemical reaction, and that changes how a measurement of either should be read.

Furostanol saponins like prototribestin have an open F ring, held open by a glucose on the C-26 hydroxyl and a free hydroxyl at C-22. Remove that C-26 glucose and the ring snaps shut into the spirostanol form. The enzyme that does it — furostanol glycoside 26-O-β-glucosidase (F26G) — has been purified and characterised, and it acts during postharvest drying and storage ^{11Reference 11Inoue K · 1996Purification and characterization of furostanol glycoside 26-O-β-glucosidase from Costus speciosus rhizomesView study →}. Prototribestin and tribestin are that exact pair: identical aglycone, identical sulfated disaccharide at C-3, differing only in the C-26 glucose and the open-versus-closed F ring. The same relationship runs protodioscin → dioscin and protogracillin → gracillin.

Three consequences follow, and all three are practical.

A tribestin number is partly a handling record. A sample dried slowly, stored long or extracted warm has converted more prototribestin into tribestin. In the closely studied case of tribulus fruit, twelve months at room temperature cut furostanol saponins by roughly 30–36% while spirostanol saponins rose by roughly 24–36%, and stir-frying — which destroys the fruit’s β-glucosidase — abolished the change ^{13Reference 13Zhang C et al. · 2020Analysis of variations in the contents of steroidal saponins in Fructus Tribuli during stir-frying treatmentView study →}. Nobody has run that experiment on the prototribestin/tribestin pair specifically, so the direction is established and the magnitude is not.

The pair should be read as a sum, not as two figures. For provenance, prototribestin + tribestin is the robust quantity; the ratio between them tells you about processing, not about origin. This is the single most useful analytical point on the page and it is not made anywhere in the primary literature.

“Standardised to furostanol saponins” excludes tribestin entirely. That phrasing, used on the Bulgarian product and much of the category, is a class specification covering the proto- forms. A well-dried, well-stored batch that has converted much of its prototribestin to tribestin will assay lower on the label’s own metric while containing the same total marker load.

Isolate vs. Plant

The boundary is unusually easy to police here, because there is almost nothing on the isolate side.

Every number published for tribestin is a concentration in a plant ^{1,4Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}, with one exception: a shared, qualitative activity descriptor from one cell screen ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. Every clinical claim in its vicinity belongs to something else — the whole standardised extract ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}, the total furostanol fraction, or the sibling molecules. This page therefore makes no isolate efficacy claim, and any product or article attributing an effect to tribestin is going beyond the literature.

Reading the other way — from molecule to plant — one inference is well supported and useful: tribestin’s presence tells you the plant grew in southeastern Europe or western Asia, and therefore that it resembles the material behind the trials ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. That is an analytical inference, not a pharmacological one, and the distinction is the whole point.

Natural Sources

Tribestin has not been reported from any plant outside Tribulus terrestris. A PubMed search for tribestin returns two records, both about T. terrestris ^{1,2Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}; a full-text search (Europe PMC) raises the total to six, of which three are reviews restating the survey and one is a cross-species sulfur-metabolite clustering that likewise lists it only from Tribulus ^{10Reference 10Abdullah-Zawawi MR et al. · 2022Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithmView study →}. Attribution check: tribestin AND "Tribulus terrestris" returns 2 of 2 PubMed records — the herb attribution is correct and complete. Within the species, sulfated saponins have been reported only from Bulgarian-origin material and, since 2008, from the neighbouring countries sharing that chemotype ^{1,7Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 7Kostova I · 2005Saponins in Tribulus terrestris — chemistry and bioactivityView study →}.

Origin	Plant part	mg/100 g DW	% dry wt
Bulgaria	Aerial parts	2–220	0.002–0.22%
Bulgaria	Leaves	62	0.062%
Bulgaria	Fruits	0.9–3.4	0.0009–0.0034%
Serbia	Aerial parts	210	0.21%
Greece	Aerial parts	24	0.024%
Turkey	Aerial parts	6.8–28	0.0068–0.028%
Turkey	Fruits	0.5–1	0.0005–0.001%
Macedonia	Aerial parts	7.3–10	0.0073–0.010%
Georgia	Aerial parts	6	0.006%
Vietnam · India	Aerial parts, fruits	not detected	0%

Three patterns are robust. Origin decides whether it is there at all — the Indian and Vietnamese zero is a real zero, not a low reading. Leaves and aerial parts carry it; fruit does not — Bulgarian fruit runs roughly twenty to sixty times below Bulgarian leaves, which matters because much of the Asian herbal use of this plant, and the Chinese Fructus Tribuli tradition, is fruit-based. And the within-chemotype spread is wide: the Bulgarian aerial range alone covers about a hundredfold, and the Serbian sample outruns every Bulgarian one, so “Bulgarian” is not a guarantee of a high number even where it is a guarantee of a non-zero one.

A data caveat, stated because it is checkable: the 2020 review’s Table 2 gives tribestin’s formula as C₃₉H₆₁NaO₁₄S. Counting from the systematic structure — diosgenin (O₃) plus glucose and rhamnose (O₁₂ after two glycosidic condensations) plus a sulfate ester (+O₃) — gives O₁₅, which is what PubChem records. The same table understates prototribestin’s oxygen count by one in the same way. The formulas in that compilation should not be quoted; the concentration figures, which come from the primary paper, are a separate matter and are used here.

Discovery & Synthesis

Tribestin’s first isolation report is not in PubMed, and this should be stated plainly rather than papered over. The 2008 chemotype survey attributes the occurrence of both sulfated markers to Kostova and colleagues in 2002 ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}. The Kostova 2002 paper indexed under that description — Two new sulfated furostanol saponins from Tribulus terrestris — reports methylprototribestin and prototribestin, both furostanols, and does not announce a new spirostanol ^{3Reference 3Kostova I et al. · 2002Two new sulfated furostanol saponins from Tribulus terrestrisView study →}. Its structure elucidation did include “chemical transformation,” which for a furostanol conventionally means converting it to the corresponding spirostanol to confirm the aglycone; that is a plausible route by which tribestin was characterised in the same work, but it is an inference and is not asserted here.

The earliest retrievable primary appearance is 2004, when Conrad, Dinchev, Klaiber, Mika, Kostova and Kraus, working at the University of Hohenheim and the Bulgarian Academy of Sciences, isolated the new furostanol saponin tribol from Bulgarian aerial parts “together with the known spirostanol saponins 2 and 3 and sitosterol glucoside” ^{5Reference 5Conrad J et al. · 2004A novel furostanol saponin from Tribulus terrestris of Bulgarian originView study →} — and a later review cites that paper as its source for tribestin ^{6Reference 6Zhu W et al. · 2017ReviewA review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestrisView study →}. Either way, the compound was already “known” by 2004, and the name follows the group’s house convention: the proto- prefix on prototribestin marks it as the furostanol precursor of tribestin, exactly as protodioscin relates to dioscin.

There is no total synthesis, no commercial production and no analytical reference standard in general circulation. All published material came from column chromatography of plant extract. That absence is not incidental — it is the practical reason the tribulus industry standardises on protodioscin rather than on the marker pair that would actually settle provenance. Patents: not yet researched.

Toxicity & Safety

The verdict is not characterised, and the unknown grading is literal. No toxicology study of tribestin exists — no acute or repeat-dose study, no genotoxicity, no reproductive or developmental work, no haemolysis assay, no interaction data. It has never been administered to an animal. The one biological experiment it appears in was a cancer-cell screen, and even there no compound-specific number was published ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}.

That is not the same as a clean record, and three specific things argue against reading it as one.

Safety at a Glance

Toxicity unknown

No adverse effect has ever been attributed to tribestin. It has also never been tested — those are different statements, and only the second one is informative.
Long incidental human exposure at low levels. Bulgarian-chemotype tribulus preparations containing it have been consumed for decades, at well under a quarter of one percent of dry plant weight, with no signal specific to this molecule ^{1,8Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}.
Zero toxicology data. Not even a haemolysis assay, which is the baseline test for a saponin. The unknown grading describes the literature, not the molecule’s safety.
No reproductive or developmental data. Nothing is known about use in pregnancy or breastfeeding; the parent herb is conventionally avoided in pregnancy and that caution carries across.
Saponins are membrane-active. The structurally closest Tribulus spirostanol with published biophysics, tribulosin, measurably perturbs lipid bilayers. Tribestin should be assumed haemolytic in vitro until measured, and any concentrated, injected or nanoformulated preparation treated as an unknown.
A sibling spirostanol from the same plant is a documented toxin. Terrestrosin D was implicated in hepatorenal toxicity in a 28-day rat study and in cell assays ^{14Reference 14Sun XC et al. · 2022Terrestrosin D, a spirostanol saponin from Tribulus terrestris L. with potential hepatorenal toxicityView study →}. Structural proximity is not evidence of shared toxicity, but it removes any presumption that this class is benign by default.
A “Bulgarian tribulus” label is not a safety guarantee. The metabolomics study built to authenticate this plant also found commercial products spiked with PDE5 inhibitors and anabolic steroids, and others cut with undisclosed green tea and citrus compounds ^{15Reference 15Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}.

Full Safety & Interactions Detail

No adverse effect specific to tribestin has been reported and no study has been designed to find one — its entire primary record is one analytical survey ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}, one re-isolation ^{5Reference 5Conrad J et al. · 2004A novel furostanol saponin from Tribulus terrestris of Bulgarian originView study →} and one cell screen ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}. What can be reasoned about is class behaviour and plant context.

As an ~825 Da sulfated glycoside, tribestin is very unlikely to be absorbed intact, which limits systemic exposure but places it, like other saponins, in the gut lumen where surfactant effects — local irritation, altered membrane permeability, possibly enhanced absorption of co-administered compounds — are the plausible actions. None has been measured for this compound. The one relevant in-vitro band, the panel’s 12.64–20.62 µg/mL growth-inhibitory range, sits in exactly the territory where saponin detergency dominates, and it was reported without a normal-cell comparator ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}.

At the herb level, Tribulus terrestris is not benign in every context: terrestrosin D carries a hepatorenal signal in rats ^{14Reference 14Sun XC et al. · 2022Terrestrosin D, a spirostanol saponin from Tribulus terrestris L. with potential hepatorenal toxicityView study →}, β-carboline alkaloids (harman, harmine) occur in trace and variable amounts and are implicated in the locomotor “staggers” syndrome of grazing sheep, and isolated case reports of hepatotoxicity and nephrotoxicity attach to tribulus products. None of this is tribestin’s and it would be wrong to transfer it — but it is the reason not to read “no data” as “no risk”. The full picture belongs on the tribulus monograph, where intake is actually decided.

The most concrete practical hazard near this molecule is adulteration, not toxicity. The 2025 LC-HRMS survey of commercial tribulus supplements confirmed PDE5 inhibitors and anabolic steroids in spiked samples, found undisclosed green tea and citrus constituents in some commercial products, and flagged spirost-4-ene-3,12-dione as an indicator of steroidal saponin decomposition during storage or processing ^{15Reference 15Gođevac D et al. · 2025LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplementsView study →}.

For a category bought on a hormonal claim it cannot deliver, that is the risk worth attending to.

There is no reproductive or developmental data on tribestin, and none on tribulus adequate to fill the gap.

Dosage

There is no dose. Tribestin has never been given to a human being or an animal, as an isolate or otherwise, and no dosing study exists to extrapolate from. Every published figure is either a concentration in a plant or a concentration in a cell-culture well.

Setting	Form	Concentration
MDR reversal screen (mouse lymphoma, in vitro)	isolated tribestin, in medium	panel ID₅₀ 12.64–20.62 µg/mL; no tribestin-specific value published ^{2Reference 2Ivanova A et al. · 2009AnimalScreening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulatorsView study →}
Plant material, European/west-Asian chemotype	whole dried aerial parts	2–220 mg/100 g dry weight ^{1,4Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →Reference 4Ștefănescu R et al. · 2020ReviewA comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris LView study →}
Plant material, Indian/Vietnamese chemotype	whole dried aerial parts, fruit	not detected ^{1Reference 1Dinchev D et al. · 2008Distribution of steroidal saponins in Tribulus terrestris from different geographical regionsView study →}
Human clinical use	whole standardised extract, not the molecule	Tribestan tablets, standardised on furostanol saponins — a fraction tribestin is not in ^{8Reference 8Kamenov Z et al. · 2017RCTEvaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trialView study →}

Real-world exposure is set almost entirely by where the plant grew and secondarily by how it was dried. A European or west-Asian aerial-parts preparation carries it at up to roughly 0.2% of dry plant weight; an Indian or Vietnamese preparation carries none. Neither figure is a recommendation, and no clinical claim here rests on either.

For what the herb itself has actually been studied at, see tribulus.

References

Dinchev D, Janda B, Evstatieva L, Oleszek W, Aslani MR, Kostova I (2008). Distribution of steroidal saponins in Tribulus terrestris from different geographical regions. Phytochemistry 69:176–186. https://pubmed.ncbi.nlm.nih.gov/17719068/
Ivanova A, Serly J, Dinchev D, Ocsovszki I, Kostova I, Molnar J (2009). Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators. In Vivo 23:545–550. https://pubmed.ncbi.nlm.nih.gov/19567388/
Kostova I, Dinchev D, Rentsch GH, Dimitrov V, Ivanova A (2002). Two new sulfated furostanol saponins from Tribulus terrestris. Zeitschrift für Naturforschung C 57:33–38. https://pubmed.ncbi.nlm.nih.gov/11926540/
Ștefănescu R, Tero-Vescan A, Negroiu A, Aurică E, Vari CE (2020). A comprehensive review of the phytochemical, pharmacological, and toxicological properties of Tribulus terrestris L. Biomolecules 10:752. https://pubmed.ncbi.nlm.nih.gov/32408715/
Conrad J, Dinchev D, Klaiber I, Mika S, Kostova I, Kraus W (2004). A novel furostanol saponin from Tribulus terrestris of Bulgarian origin. Fitoterapia 75:117–122. https://pubmed.ncbi.nlm.nih.gov/15030914/
Zhu W, Du Y, Meng H, Dong Y, Li L (2017). A review of traditional pharmacological uses, phytochemistry, and pharmacological activities of Tribulus terrestris. Chemistry Central Journal 11:60. https://pubmed.ncbi.nlm.nih.gov/29086839/
Kostova I, Dinchev D (2005). Saponins in Tribulus terrestris — chemistry and bioactivity. Phytochemistry Reviews 4:111–137. https://doi.org/10.1007/s11101-005-2833-x
Kamenov Z, Fileva S, Kalinov K, Jannini EA (2017). Evaluation of the efficacy and safety of Tribulus terrestris in male sexual dysfunction — a prospective, randomized, double-blind, placebo-controlled clinical trial. Maturitas 99:20–26. https://pubmed.ncbi.nlm.nih.gov/28364864/
Gjulemetowa R, Tomowa M, Simowa M, Pangarowa T, Peewa S (1982). [Determination of furostanol saponins in the preparation Tribestan] [in German]. Pharmazie 37:296. https://pubmed.ncbi.nlm.nih.gov/6896581/
Abdullah-Zawawi MR, Govender N, Karim MB, Altaf-Ul-Amin M, Kanaya S, Mohamed-Hussein ZA (2022). Chemoinformatics-driven classification of Angiosperms using sulfur-containing compounds and machine learning algorithm. Plant Methods 18:118. https://pubmed.ncbi.nlm.nih.gov/36335358/
Inoue K, Ebizuka Y (1996). Purification and characterization of furostanol glycoside 26-O-β-glucosidase from Costus speciosus rhizomes. FEBS Letters 378:157–160. https://pubmed.ncbi.nlm.nih.gov/8549824/
Song X, Yuan Y, Wang S, Sun X, Zhang C, Gao P, Shi L (2021). Pharmacokinetic comparisons of six steroid saponins in rat plasma following oral administration of crude and stir-fried Fructus Tribuli extracts by UHPLC-MS/MS. Biomedical Chromatography 35:e5163. https://pubmed.ncbi.nlm.nih.gov/33939847/
Zhang C, Wang S, Guo F, Ma T, Zhang L, Sun L, Wang Y, Zhang X (2020). Analysis of variations in the contents of steroidal saponins in Fructus Tribuli during stir-frying treatment. Biomedical Chromatography 34:e4788. https://pubmed.ncbi.nlm.nih.gov/31944362/
Sun XC, Song X, Guo F, Yuan Y, Wang S, Wang XY, Han B, Zhang C, Liu JT (2022). Terrestrosin D, a spirostanol saponin from Tribulus terrestris L. with potential hepatorenal toxicity. Journal of Ethnopharmacology 283:114716. https://pubmed.ncbi.nlm.nih.gov/34626781/
Gođevac D, Jeremić JS, Cvetković M, Simić K, Sofrenić I, Ljujić J, Popović L, Gašić U, Hoang YN, Huan T, Ivanović S (2025). LC-MS-based metabolomics for detecting adulteration in Tribulus terrestris-derived dietary supplements. Food Chemistry: X 27:102476. https://pubmed.ncbi.nlm.nih.gov/40290465/